Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Janux Therapeutics (JANX) Change in Accured Expenses (2020 - 2025)

Janux Therapeutics (JANX) has disclosed Change in Accured Expenses for 6 consecutive years, with -$4.5 million as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses fell 176.38% to -$4.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.3 million through Dec 2025, up 42.11% year-over-year, with the annual reading at $6.3 million for FY2025, 42.11% up from the prior year.
  • Change in Accured Expenses for Q4 2025 was -$4.5 million at Janux Therapeutics, down from $6.2 million in the prior quarter.
  • The five-year high for Change in Accured Expenses was $6.2 million in Q3 2025, with the low at -$4.5 million in Q4 2025.
  • Average Change in Accured Expenses over 5 years is $861100.0, with a median of $971500.0 recorded in 2021.
  • The sharpest move saw Change in Accured Expenses surged 605.87% in 2022, then plummeted 483.57% in 2024.
  • Over 5 years, Change in Accured Expenses stood at $1.9 million in 2021, then tumbled by 47.68% to $1.0 million in 2022, then tumbled by 57.61% to $426000.0 in 2023, then tumbled by 483.57% to -$1.6 million in 2024, then tumbled by 176.38% to -$4.5 million in 2025.
  • According to Business Quant data, Change in Accured Expenses over the past three periods came in at -$4.5 million, $6.2 million, and $2.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.